476 related articles for article (PubMed ID: 33955820)
21. Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma.
Wu ZH; Yang DL; Wang L; Liu J
Front Immunol; 2021; 12():793343. PubMed ID: 34925377
[TBL] [Abstract][Full Text] [Related]
22. Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.
Li R; Zhao W; Liang R; Jin C; Xiong H
Front Mol Biosci; 2022; 9():917839. PubMed ID: 35847972
[No Abstract] [Full Text] [Related]
23. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network.
Zhou W; Chen Y; Luo R; Li Z; Jiang G; Ou X
Pathol Oncol Res; 2021; 27():601693. PubMed ID: 34257558
[TBL] [Abstract][Full Text] [Related]
24. Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.
Li Y; He X; Zhang X; Xu Y; Wu Y; Xu X
Life Sci; 2021 Jan; 265():118799. PubMed ID: 33220285
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma.
Gao W; Li L; Han X; Liu S; Li C; Yu G; Zhang L; Zhang D; Liu C; Meng E; Hong S; Wang D; Guo P; Shi G
BMC Cancer; 2021 Mar; 21(1):331. PubMed ID: 33789609
[TBL] [Abstract][Full Text] [Related]
26. Cyclin B1 acts as a tumor microenvironment-related cancer promoter and prognostic biomarker in hepatocellular carcinoma.
Hou Y; Wang X; Wang J; Sun X; Liu X; Hu H; Fan W; Zhang X; Wu D
J Int Med Res; 2021 May; 49(5):3000605211016265. PubMed ID: 34044639
[TBL] [Abstract][Full Text] [Related]
27. CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates.
Nie Y; Jiang MC; Liu C; Liu Q; Zhu X
Front Oncol; 2021; 11():637023. PubMed ID: 33869023
[TBL] [Abstract][Full Text] [Related]
28. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
[TBL] [Abstract][Full Text] [Related]
29. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Wang N; Zhou X; Tang F; Wang X; Zhu X
Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma.
Liu Z; Liu L; Guo C; Yu S; Meng L; Zhou X; Han X
Int Immunopharmacol; 2021 Dec; 101(Pt B):108340. PubMed ID: 34789428
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Yu ZL; Zhu ZM
Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
[TBL] [Abstract][Full Text] [Related]
32. A prognostic signature established based on genes related to tumor microenvironment for patients with hepatocellular carcinoma.
Cui Z; Li G; Shi Y; Zhao X; Wang J; Hu S; Chen C; Li G
Aging (Albany NY); 2024 Apr; 16(7):6537-6549. PubMed ID: 38579170
[TBL] [Abstract][Full Text] [Related]
33. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
Li C; Liu T; Liu Y; Zhang J; Zuo D
J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
[TBL] [Abstract][Full Text] [Related]
35. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
Huang S; Zhang J; Lai X; Zhuang L; Wu J
Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
[No Abstract] [Full Text] [Related]
38. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
39. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
40. Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma.
Qian H; Song S; Tian Y; Qi L; Gao H; Yuan L
Medicine (Baltimore); 2021 Apr; 100(15):e25374. PubMed ID: 33847635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
